SEOUL, July 12 (Korea Bizwire) — A new artificial intelligence (AI) algorithm has been developed that can predict lung cancer patients’ response to immuno-oncology treatment on the basis of their clinical information. A joint research team from the Yonsei Cancer Hospital and the Yonsei University Medical School said it had developed a machine learning-based algorithm [...]
RENSSELAER, N.Y., Jan. 31 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, expands its premier immuno-oncology portfolio with the launch of the new B2m-NOG mouse model. Immuno-oncology leverages the body’s immune system to fight cancer, increasing the ability to target the disease. Animal models used in this therapeutic development [...]
SAN DIEGO, Apr. 26 (Korea Bizwire) — Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, enhances its existing portfolio of humanized drug target models (HuGEMM™) by launching a new transgenic CD3E model [...]
SEOUL, Jan. 11 (Korea Bizwire) — LG Chem Ltd., South Korea’s top chemicals company, said Thursday that it will concentrate its research on developing new drugs for metabolic diseases and immuno-oncology treatment. LG Chem also said it will speed up the development process for new drugs through its open innovation program, which is designed to [...]